1. 115P Therapeutic efficacy of combining the tumour checkpoint controller BAL101553 (lisavanbulin) and immunomodulation in two mouse glioma models with different immunological status. (15th December 2019) Authors: Genoud, V; Marinari, E; Bes, V; Dietrich, P-Y; McSheehy, P; Bachmann, F; Lane, H; Walker, P R Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗